Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

New haematology analyser helps speed treatment decision making at Bedford Hospital's oncology unit

Horiba Medical : 07 February, 2008  (New Product)
The implementation of an ABX Pentra 60C+ haematology analyser at the Macmillan Primrose Unit within Bedford Hospital has had a positive impact enabling results to be made available to clinicians within minutes thereby allowing treatment decisions to be made quickly.
The decision to install the Horiba ABX haematology analyser at the Bedford-based specialist oncology unit was the result of delays when processing FBC/Diff test requests prior to chemotherapy treatment and during routine follow-up consultations.

The compact ABX Pentra 60C+ bench top analyser is ideal for point-of-care use within oncology departments due to the 5-part cytochemical differential for white blood cells. This makes it useful for monitoring patients receiving chemotherapy and follow-up care for various cancers.

“One of the great advantages of having installed the ABX Pentra 60C+ is the rapid and accurate processing of samples. As many of our patients are difficult to take full blood samples from, we can also run paediatric samples on the analyser,” remarked Jill Bunney, oncology phlebotomist at the Primrose Unit. “This not only reduces stress for the patient and clinician, but also prevents unnecessary sample re-runs and time wastage. Patients often remark with amazement on the ‘instant results available’ and this has been another great advantage to us.”

“The analyser is also very easy to use and maintain compared to our previous analyser,” added Jill Bunney. “We’ve found that the ABX Pentra 60C+ computer/analyser interface enables greater user control and the results printout can be readily understood by all clinicians, as it is clear and easy to read.”

Another key benefit found by the Primrose Unit is the ABX Pentra 60C+’s technology being compatible with the main hospital laboratory which uses Horiba ABX’s high throughput analysers with integrated slide maker and stainer, meaning QA checks can be undertaken across all Horiba ABX analysers at Bedford.

Technological compatibility also ensures consistently accurate results, which require no time consuming cross checks with the main laboratory. Furthermore, with daily control samples run with few repeats compared to their previous instrument, the Primrose Unit has even more time to process patient tests and thus clinic waiting times are reduced.

On-board computer monitoring of reagent usage and the use of non-hazardous reagents has made day to day maintenance of the analyser extremely safe, easy and efficient. The rapid response from Horiba ABX service engineers has meant that the ABX Pentra 60C+ has been 100 percent operational since it was installed, with 'down-time' now completely a thing of the past.

The ABX Pentra 60C+ has made a difference to clinics at the Macmillan Primrose Unit – for both staff and patients.

“I would not hesitate to recommend the use of this instrument in any point-of-care setting,” concluded Jill Bunney.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   Â© 2012
Netgains Logo